4.6 Review

Tourette Syndrome: Evolving Concepts

期刊

MOVEMENT DISORDERS
卷 26, 期 6, 页码 1149-1156

出版社

WILEY
DOI: 10.1002/mds.23618

关键词

attention deficit disorder; obsessive compulsive disorder; tics; Tourette syndrome

资金

  1. Allergan, Inc
  2. Allon Therapeutics
  3. Ceregene, Inc
  4. Chelsea Therapeutics
  5. Diana Helis Henry Medical Research Foundation
  6. EMD Serono
  7. Huntington's Disease Society of America
  8. Huntington Study Group
  9. Impax Pharmaceuticals
  10. Ipsen Limited
  11. Lundbeck Inc
  12. Michael J Fox Foundation for Parkinson Research
  13. Medtronic
  14. Merz Pharmaceuticals
  15. National Institutes of Health
  16. National Parkinson Foundation
  17. Neurogen
  18. St. Jude Medical
  19. Teva Pharmaceutical Industries Ltd
  20. University of Rochester
  21. Parkinson Study Group

向作者/读者索取更多资源

Tourette syndrome is a common childhood-onset neurobehavioral disorder characterized by multiple motor and phonic tics affecting boys more frequently than girls. Premonitory sensory urges prior to tic execution are common, and this phenomenon helps to distinguish tics from other hyperkinetic movement disorders. Tourette syndrome is commonly associated with attention deficit hyperactivity disorder, obsessive-compulsive disorder, learning difficulties, and impulse control disorder. The pathophysiology of this complex disorder is not well understood. Involvement of basal ganglia-related circuits and dopaminergic system has been suggested by various imaging and postmortem studies. Although it is considered a genetic disorder, possibly modified by environmental factors, an intense search has thus far failed to find causative genes. Symptomatic treatment of tics chiefly utilizes various alpha adrenergic agonists, antidopaminergic drugs, topiramate, botulinum toxin, and deep brain stimulation. Habit reversal therapy and other behavioral approaches may be a reasonable option for some cases. Improved understanding of Tourette syndrome should lead to better symptomatic and more effective pathogenesis-targeted therapies. (C) 2011 Movement Disorder Society

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据